Know What's Happening in Healthcare
Know What's Happening in Healthcare
FDA approves KRESLADI, first CIRM‑backed gene‑editing therapy
The FDA cleared KRESLADI, a gene‑editing treatment from Rocket Pharmaceuticals for severe leukocyte adhesion deficiency‑I in children, eliminating the need for a bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine to receive approval.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
Researchers used laser powder bed fusion (LPBF) to 3D‑print zinc‑silver‑copper alloys and demonstrated in‑vitro cytocompatibility, indicating the material could serve as a biodegradable implant. Zinc offers a middle‑ground degradation rate between magnesium and iron, while silver and copper add antimicrobial and strengthening effects. The study shows that, despite zinc’s low boiling point, a controlled LPBF process can avoid excessive vaporization and produce alloys that meet standard cell‑viability thresholds. These findings pave the way for patient‑specific, resorbable hardware pending further mechanical and in‑vivo validation.
In 2026 emergency response agencies will pivot from reactive tactics to data‑driven operations, leveraging predictive analytics, seamless interoperability, and community‑care models. Real‑time analytics will forecast demand spikes, enabling pre‑positioning of resources and faster response times. Integrated platforms will allow instant...
Ceiling Rail System Gives Wheelchair Users New Freedom at Home by @SusieM414141 #MedTech #Healthcare #HealthTech #Tech #Technology https://t.co/ckMgvssrGM
A randomized, double‑blind trial in Japan found that a daily 100 ml drink containing 10 billion CFU of Lactiplantibacillus plantarum 299v reduced bowel‑movement frequency and days with defecation in healthy adults prone to loose stools. After eight weeks, the probiotic group averaged 6.7...
CVS Health announced a strategic partnership with Google Cloud to launch Health100, an AI‑native consumer health platform that unifies patients, providers, payers and digital services. The platform leverages Google Gemini models, BigQuery and the Cloud Healthcare API to deliver an...
The National Advisory Committee on Institutional Quality and Integrity (NACIQI) voted 12‑to‑0 to reject renewal of the Council on Naturopathic Medical Education’s (CNME) federal recognition, citing poor student outcomes, demographic justifications, and concerns over faculty expertise and finances. CNME, which...
PsyMetrics unveiled its Healthcare Behavioral Assessment Suite, an AI‑driven psychometric platform aimed at curbing the chronic turnover in hospitals, clinics, and medical support services. The tool leverages 30 years of industrial‑organizational psychology data to map candidates' behavioral traits to the...
Indiana’s life‑sciences sector is rapidly expanding, now encompassing over 3,300 companies that employ roughly 70,000 workers and generate a $102 billion economic impact. Flagship firms such as Eli Lilly are driving major investments, including a $13 billion Medicine Foundry slated to create 400...
Patients diagnosed with hypertrophic cardiomyopathy (HCM) must scrutinize both prescription and over‑the‑counter drugs because certain classes can worsen obstruction or fluid balance. Vasodilators, ACE inhibitors, ARBs, nitrates, and dihydropyridine calcium‑channel blockers may increase heart stress in obstructive HCM, while non‑dihydropyridine...
Managing endometriosis pain requires a personalized, multimodal approach that blends lifestyle changes, medical therapies, and, when needed, surgery. Dr. Megan Billow emphasizes tailoring treatment to individual symptoms, reproductive goals, and quality‑of‑life priorities. Options range from diet, regular exercise, NSAIDs, CBT,...
A Trump‑era memo reveals that roughly $9.7 million in contraceptives purchased by USAID for low‑income African nations became stranded in a Belgian warehouse after the agency was dismantled. By September 2025 only $1.6 million remained usable, while $8.1 million spoiled due to lack...
Jiangsu Aidea Pharmaceutical, a Shanghai‑Star Market listed firm specializing in HIV/AIDS therapies, is preparing a Hong Kong IPO to fund its expansion into the United States and Europe. The company projects the global AIDS‑treatment market to exceed $1.45 billion by 2027...
Researchers developed a random‑forest machine learning model that predicts hepatocellular carcinoma (HCC) risk using only routine clinical data—demographics, electronic health records, and standard blood tests. In a UK Biobank cohort the model achieved an AUROC of 0.88, and external validation...
A 19‑year Swedish cohort study of 20,811 adults aged 35‑64 found that mentally passive sedentary activities, such as TV watching, increase dementia risk, while mentally active sitting—reading or desk work—significantly lowers it. Substituting equal amounts of passive with active sedentary...
A recent review of 81 registered trials and 64 peer‑reviewed human studies finds molecular hydrogen therapy shows measurable benefits across multiple disease systems. The smallest molecule in existence appears to improve cardiovascular outcomes, enhance cancer treatment tolerance, reduce lung inflammation,...
Dr. Joseph Sansone has filed Senator Ron Johnson’s investigative subcommittee letter as supplemental authority in his appellate lawsuit against Florida Governor Ron DeSantis and Attorney General James Uthmeier, alleging that mRNA COVID‑19 injections function as biological weapons. The filing cites...
Consumer Reports’ latest investigation revealed that more than 66% of protein powders contain detectable lead, and two plant‑based formulas register 12‑ to 16‑times the amount considered safe for a single day. The findings raise urgent safety questions for a market...
Kermit Gosnell, the former Philadelphia doctor convicted of murdering three newborns and a patient, died on March 1 at age 85 while incarcerated at a Pennsylvania prison hospital. His death closes a chapter on a case that reshaped abortion oversight...
Lenz Therapeutics' shares slid 11.2% after the biotech reported a Q4 loss of $1.16 per share on $1.6 million in revenue, well below analyst expectations. The miss stemmed from weaker-than-anticipated uptake of its newly launched VIZZ eye‑drop and a surge in...
Smartwatches, period‑tracking apps and AI‑enabled glasses are harvesting unprecedented volumes of biometric data. FTC actions against femtech firms and mounting legal pressure in abortion‑restrictive states have turned the devices that promise wellness into privacy flashpoints.
Google’s Articulate Medical Intelligence Explorer (AMIE) completed a prospective clinical trial with 100 patients at Beth Israel Deaconess Medical Center, collecting histories and delivering diagnostic differentials before primary‑care visits. The study reported zero safety stops, a correct final diagnosis in...
New research published in the Journal of Vascular and Interventional Radiology shows percutaneous cryoablation delivers high local control for medically inoperable stage IA non‑small cell lung cancer, especially tumors under 2 cm. In a single‑center analysis of 176 patients, one‑year and three‑year...
CMS signaled that several of its more ambitious 2027 Affordable Care Act exchange proposals will be delayed beyond this year, after reviewing over 2,800 public comments. The agency plans to postpone items such as ten‑year catastrophic‑plan contracts, network‑less qualified health...
Health New Zealand unveiled a national diabetes roadmap, overseen by endocrinologist Sir Jim Mann, after reporting $2.1 billion NZD spent on treatment in 2024/25. The plan targets a projected cost surge to $4.8 billion NZD by 2040 and promises system‑level actions such...
The Indian health ministry announced the country's first national patient‑recovery guidelines on micronutrient supplementation, developed by the Indian Medical Association and P&G Health. The guidebook targets doctors across specialties, urging them to integrate vitamins and minerals into treatment plans for...
Labor and delivery nurse Kim, known as @nursekimwellness on TikTok, posted a video naming five shocking behaviors by fathers in delivery rooms. The clip quickly went viral, prompting hospitals and parenting groups to discuss how to set clearer expectations for...
A new National Guardian review finds that roughly two‑thirds of temporary NHS staff in England feel they have no voice, with fear of losing shifts the primary deterrent to speaking up. Ethnic minority temps report even higher levels of silence,...
Viatris Inc. outlined its long‑term growth outlook, emphasizing a balanced portfolio that spans low‑cost generics, established branded products, and a pipeline of innovative medicines. Management highlighted strategic investments in R&D, geographic expansion in emerging markets, and cost‑efficiency initiatives aimed at...
Hong Kong Science and Technology Parks Corporation convened leading life‑science firms, investors and partners at its CTC Marketplace to showcase the city’s emerging health‑tech ecosystem. The event highlighted Hong Kong’s strengths in translational research, clinical‑trial capacity and AI‑driven drug discovery,...
Lawrence Tallon, the MHRA chief, is set to oversee the launch of the Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 on April 28, 2026. The amendment represents the most extensive overhaul of U.K. clinical‑trial rules in two decades, targeting faster approval,...
The article argues that brain‑computer interfaces must evolve from one‑way readers to truly bidirectional systems that both decode and write native neural representations. It highlights recent advances in high‑density electrode arrays that approach synapse‑scale resolution, and suggests optogenetic organoids and...
New York is considering a $1.5 billion health‑care funding increase that will be divided between hospitals and nursing homes, but the exact split remains uncertain. Nursing‑home operators are pressing for at least $750 million in Medicaid‑related support, arguing that current rates have...
When we published our H2H in @NEJM Ian Jordan raised an excellent letter re SSRI discontinuation & how it might impact response. We looked & found he was right. Those who discontinued SSRIs and went back on (escitalopram) did far...
Proud of the work of our Seaport team & collaborators published today in @ScienceTM. This ~13 page peer reviewed paper is the first comprehensive data disclosure of our GlyphAllo™ program from discovery through initial human proof‑of‑concept.
The Centers for Medicare & Medicaid Services (CMS) issued a Request for Information seeking feedback on proposed rules that would tighten ownership and identity verification for Medicare‑enrolled providers and suppliers. The agency is weighing a citizenship or permanent‑resident requirement for...
So pleased that people like Professor Denis Migliorini @MiglioriniDenis are leading the fight against solid tumors such as GBM / glioblastoma: he is an inspiration. https://t.co/8ohKJG4mQq
Corporations as vectors of chronic disease, @NEJM Calling out 6 commercial products that contribute to 31% of all deaths globally. Chemicals include pesticides, PFAS, manufactured. And counterstrategies to address https://t.co/b6iDYcEyct https://t.co/JYJId8uNyV
Italian neurosurgeon Sergio Canavero, famed for his controversial head‑transplant ambitions, claims a $100 million operation would require an 80‑person surgical team and could eventually give patients a new body. He cites early animal work—rat nerve‑fusion with polyethylene glycol, monkey and dog head...
Here it is again. Amazing how researchers could get away with this back then. Regular systematic bias of excluding TAD nonresponders. Also note another thing inconsistent with core psychedelic trial period i.e., that Ps were allowed to continue psychotherapy outside...
When Susan Monarez was fired as #CDC director, the administration knew it has 210 days to nominate a replacement. Today is Day 210 & no nominee. Finding someone who can gain Senate approval & Sec Kennedy's approval may be proving...
The FDA’s Regulatory Education for Industry (REdI) Annual Conference will take place May 19‑20, 2026, offering both virtual and in‑person sessions at the White Oak Campus in Maryland. The two‑day program features three dedicated tracks—drugs, devices, and biologics—allowing participants to...
"We health professionals must call urgent attention to this silent but deadly assault [EPA dismantling ] on American's health...." @NEJM https://t.co/FJYbZh5O1m https://t.co/hajEmMWHTs
Integrating PRN nurses into existing care teams requires more than ad‑hoc scheduling; it demands structured onboarding, clear role definitions, and robust communication channels. Facilities should assign permanent mentors, provide concise orientation, and grant access to electronic health records and equipment....
Denali Therapeutics received accelerated FDA approval for Avlayon (tividenofusp alfa‑eknm), the first enzyme replacement therapy designed to cross the blood‑brain barrier for Hunter syndrome. The approval is based on a phase 1/2 trial of 47 boys up to 18 years, showing...
Qualified Health announced a $125 million Series B round, bringing its total funding to $155 million and led by NEA alongside a slate of top health‑tech investors. The company offers an enterprise‑wide AI infrastructure platform that replaces fragmented point‑solution approaches. Early adopters such...
The FDA’s Center for Drug Evaluation and Research released its FY 2025 GDUFA Science & Research Report, detailing more than 50 funded projects across eight priority scientific initiatives. The program targets bioequivalence, manufacturing standards, and advanced analytical methods to streamline abbreviated...
Under the Hatch‑Waxman law, generic manufacturers must file a Paragraph IV certification asserting that a listed patent is invalid, unenforceable, or not infringed to obtain FDA approval. The first substantially complete ANDA with such a certification secures a 180‑day exclusivity period,...
Researchers at Longeveron reported that a single infusion of laromestrocel, a mesenchymal stem‑cell therapy derived from donors aged 14‑18, significantly boosted mobility in frail seniors. In a double‑blind trial of about 150 participants aged 70‑85, the highest dose (200 million cells)...
